Evaluating the Safety and Serum Concentrations of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered in Multiple Doses and Routes to Healthy, HIV-uninfected Adults
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Cynthia Gay
University of North Carolina, Chapel Hill
Study Chair - Stephen Walsh
Brigham and Women's Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lausanne Vaccine and Immunotherapy Center Crs
Lausanne, Canton of Vaud, Switzerland
- Alabama Crs
Birmingham, Alabama, United States
- the Ponce de Leon Center Crs
Atlanta, Georgia, United States
- Brigham and Women'S Hospital Vaccine Crs (bwh Vcrs)
Boston, Massachusetts, United States
- Fenway Health (fh) Crs
Boston, Massachusetts, United States
- Columbia P&s Crs
New York, New York, United States
- Chapel Hill Crs
Chapel Hill, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2018
- Primary completion
- 7 Dec 2020
- Completion
- 7 Dec 2020
- Last update posted
- 5 Apr 2023
- Registered enrollment
- 124
- Registry id
- NCT03387150
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.